These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 439046)

  • 1. The management of renal stone disease.
    Will EJ
    J R Coll Physicians Lond; 1979 Apr; 13(2):66-9. PubMed ID: 439046
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium oxalate renal stones.
    Prien EL
    Annu Rev Med; 1975; 26():173-9. PubMed ID: 1096755
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation and medical management of the patient with calcium stone disease.
    Menon M; Krishnan CS
    Urol Clin North Am; 1983 Nov; 10(4):595-615. PubMed ID: 6636376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of calcium-salt renal calculi associated with idiopathic hypercalciuria].
    Oliver J; Liberman UA; de Vries A
    Harefuah; 1971 Dec; 81(11):554-5. PubMed ID: 5142929
    [No Abstract]   [Full Text] [Related]  

  • 5. Methylene blue as an inhibitor of stone formation.
    Ahmed K; Tawashi R
    Urol Res; 1978; 6(2):77-81. PubMed ID: 351913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of magnesium in the physiopathology and treatment of calcium renal lithiasis].
    Labeeuw M; Pozet N; Zech P; Traeger J
    Presse Med; 1987 Jan 10-17; 16(1):25-7. PubMed ID: 2949294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of drug therapy efficacy to prevent recurrence of calcium oxalate kidney stone formation.
    Sarig S; Garti N; Azoury R; Perlberg S; Wax Y
    J Urol; 1983 Jun; 129(6):1258-61. PubMed ID: 6854813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dietary modification on urinary stone risk factors.
    Taylor EN; Curhan GC
    Kidney Int; 2006 Mar; 69(6):1093. PubMed ID: 16528260
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of phosphates in patients with calcareous renal calculi.
    Thomas WC
    Kidney Int; 1978 May; 13(5):390-6. PubMed ID: 351267
    [No Abstract]   [Full Text] [Related]  

  • 10. Low inhibition of crystal agglomeration and citrate excretion in recurrent calcium oxalate stone formers.
    Kok DJ; Papapoulos SE; Bijvoet OL
    Contrib Nephrol; 1987; 58():73-7. PubMed ID: 3691150
    [No Abstract]   [Full Text] [Related]  

  • 11. Control of crystallization in urine.
    Howard JE; Thomas WC
    Am J Med; 1968 Nov; 45(5):693-9. PubMed ID: 5687258
    [No Abstract]   [Full Text] [Related]  

  • 12. Metastable supersaturation. Physicochemical studies provide new insights into formation of renal and biliary tract stones.
    Holzbach RT; Pak CY
    Am J Med; 1974 Feb; 56(2):141-3. PubMed ID: 4812071
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical management of urinary stone disease.
    Park S
    Expert Opin Pharmacother; 2007 Jun; 8(8):1117-25. PubMed ID: 17516875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effectiveness of prophylactic dietary treatment in renal stones].
    Iguchi M; Umekawa T; Takamura C; Kiwamoto H; Ishikawa Y; Kodama M; Katayama Y; Takada M; Katoh Y; Kataoka K
    Hinyokika Kiyo; 1991 Oct; 37(10):1125-31. PubMed ID: 1755403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and mode of action of orthophosphates in patients with calcareous renal calculi.
    Thomas WC
    Trans Am Clin Climatol Assoc; 1972; 83():113-24. PubMed ID: 5040108
    [No Abstract]   [Full Text] [Related]  

  • 16. Caffeine prevents kidney stone formation by translocation of apical surface annexin A1 crystal-binding protein into cytoplasm: In vitro evidence.
    Peerapen P; Thongboonkerd V
    Sci Rep; 2016 Dec; 6():38536. PubMed ID: 27924845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary phytate in calcium oxalate stone formers and healthy people--dietary effects on phytate excretion.
    Grases F; March JG; Prieto RM; Simonet BM; Costa-Bauzá A; García-Raja A; Conte A
    Scand J Urol Nephrol; 2000 Jun; 34(3):162-4. PubMed ID: 10961468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylene blue in renal calculi. Results of five-year study.
    Smith MJ
    Urology; 1975 Dec; 6(6):676-9. PubMed ID: 1202715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nifedipine on urinary calcium and oxalate excretion in renal stone formers.
    Baggio B; Gambaro G; Marchini F; Cicerello E; Borsatti A
    Nephron; 1986; 43(3):234-5. PubMed ID: 3724934
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inhibitors of crystallization and calcium nephrolithiasis].
    Baumann JM
    Ther Umsch; 1980 May; 37(5):363-72. PubMed ID: 6248999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.